Company
A new era for human health
Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
A signal for change
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
$3 mil +
contributed over the last 20 years to support the hospice palliative care movement in Canada
GSK Global links
Visit our Global site for additional features
Press releases
- GSK and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for JEMPERLI plus chemotherapy for all adult patients with primary advanced or first recurrent endometrial cancer
- Quebec becomes the first province to publicly reimburse Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anemia
- GSK Survey Highlights Gaps in RSV Awareness, Risk Understanding Among Vulnerable Older Canadian Adults
